Herpes Vaccine Candidates in 2026: Progress and Prospects
As we enter 2026, the global effort to develop an effective herpes simplex virus (HSV) vaccine has reached a critical turning point. The landscape was...
Read More5 articles tagged with this topic
As we enter 2026, the global effort to develop an effective herpes simplex virus (HSV) vaccine has reached a critical turning point. The landscape was...
Read More
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect approximately 3.7 billion people globally—roughly 67% for HSV-1 and 11% for...
Read More
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect a significant portion of the global population, causing recurrent painful symptoms and...
Read More
In 2025, the global effort to develop an effective herpes simplex virus (HSV) vaccine is gaining momentum with several promising candidates advancing through...
Read More
The year 2025 is seen as a pivotal moment for herpes research due to several promising clinical trials and advancements in diagnostic technologies.While there...
Read More